[
  {
    "ts": null,
    "headline": "Why BioNTech Stock Bumped Higher Today",
    "summary": "Investors were cheered by two pieces of good news concerning the biotech's most famous product.",
    "url": "https://finnhub.io/api/news?id=a1beb98dc9b480ad4fedf5597ea7a316bfe0b2b5c4dd7292e07b0d0d4c1ed16e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758581154,
      "headline": "Why BioNTech Stock Bumped Higher Today",
      "id": 136850982,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Investors were cheered by two pieces of good news concerning the biotech's most famous product.",
      "url": "https://finnhub.io/api/news?id=a1beb98dc9b480ad4fedf5597ea7a316bfe0b2b5c4dd7292e07b0d0d4c1ed16e"
    }
  },
  {
    "ts": null,
    "headline": "Podcast: Nasdaq Leads U.S. Stocks to New Records",
    "summary": "Nvidia's investment in OpenAI boosted tech stocks and the Nasdaq Composite Index Monday. Plus: Pfizer agreed to acquire GLP-1 maker Metsera. And Oracle named new co-CEOs. ? Listen to the WSJ Minute Briefing podcast.",
    "url": "https://finnhub.io/api/news?id=c3592cd64956a4a53c5ecd9b0440dae3b765bbdd8fd13318cca272f40b9f0ab3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758578402,
      "headline": "Podcast: Nasdaq Leads U.S. Stocks to New Records",
      "id": 136850983,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Nvidia's investment in OpenAI boosted tech stocks and the Nasdaq Composite Index Monday. Plus: Pfizer agreed to acquire GLP-1 maker Metsera. And Oracle named new co-CEOs. ? Listen to the WSJ Minute Briefing podcast.",
      "url": "https://finnhub.io/api/news?id=c3592cd64956a4a53c5ecd9b0440dae3b765bbdd8fd13318cca272f40b9f0ab3"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer joining GLP-1 race: How Novo & Eli Lilly compare",
    "summary": "Pfizer (PFE) is entering the weight-loss drug race with its acquisition of Metsera. BMO Capital Markets managing director of biopharma equity research Evan Seigerman Yahoo Finance Head of News Myles Udland on Market Domination to discuss how investors can play the GLP-1 trade in the pharmaceutical sector. To watch more expert insights and analysis on the latest market action, check out more Market Domination.",
    "url": "https://finnhub.io/api/news?id=2a97c38ed56329e72c1038cab397f0480622db64fd59451ea74acc8fdd3bed0d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758574800,
      "headline": "Pfizer joining GLP-1 race: How Novo & Eli Lilly compare",
      "id": 136850305,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer (PFE) is entering the weight-loss drug race with its acquisition of Metsera. BMO Capital Markets managing director of biopharma equity research Evan Seigerman Yahoo Finance Head of News Myles Udland on Market Domination to discuss how investors can play the GLP-1 trade in the pharmaceutical sector. To watch more expert insights and analysis on the latest market action, check out more Market Domination.",
      "url": "https://finnhub.io/api/news?id=2a97c38ed56329e72c1038cab397f0480622db64fd59451ea74acc8fdd3bed0d"
    }
  },
  {
    "ts": null,
    "headline": "US Equity Indexes Higher as Tech Stocks Rally, Gold Sets New Record",
    "summary": "US equity indexes were higher after the close on Monday as technology stocks rallied, while gold pri",
    "url": "https://finnhub.io/api/news?id=f4b95e776926e9b95e6ffbdad96cee161692233df88c6a5380ad9deed8c2d7f4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758572946,
      "headline": "US Equity Indexes Higher as Tech Stocks Rally, Gold Sets New Record",
      "id": 136850985,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "US equity indexes were higher after the close on Monday as technology stocks rallied, while gold pri",
      "url": "https://finnhub.io/api/news?id=f4b95e776926e9b95e6ffbdad96cee161692233df88c6a5380ad9deed8c2d7f4"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Recap: Nvidia, Oracle, Pfizer, Kenvue, Compass",
    "summary": "↗️ Nvidia (NVDA): Shares of the chip giant rose 3.9% to a record after it announced an expansive partnership with OpenAI. ↘️ Compass (COMP): The real-estate brokerage agreed to acquire Anywhere Real Estate (HOUS) for $1.",
    "url": "https://finnhub.io/api/news?id=e1ef91edd33d1c600cd7ece5b820567f9547e6e36c895d75d8ecdf0d2ce5da12",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758572418,
      "headline": "Stocks to Watch Recap: Nvidia, Oracle, Pfizer, Kenvue, Compass",
      "id": 136850986,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "↗️ Nvidia (NVDA): Shares of the chip giant rose 3.9% to a record after it announced an expansive partnership with OpenAI. ↘️ Compass (COMP): The real-estate brokerage agreed to acquire Anywhere Real Estate (HOUS) for $1.",
      "url": "https://finnhub.io/api/news?id=e1ef91edd33d1c600cd7ece5b820567f9547e6e36c895d75d8ecdf0d2ce5da12"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Claws Deeper Into The Obesity Space With $4.9 Billion Metsera Deal",
    "summary": "After two high-profile failures, Pfizer is clawing deeper into the obesity space with the $4.9 billion acquisition of Metsera.",
    "url": "https://finnhub.io/api/news?id=998ce8e35948f9336367b0ccda5079f1582f31ce7d16131aaf877388a95c08c4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758571437,
      "headline": "Pfizer Claws Deeper Into The Obesity Space With $4.9 Billion Metsera Deal",
      "id": 136850987,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "After two high-profile failures, Pfizer is clawing deeper into the obesity space with the $4.9 billion acquisition of Metsera.",
      "url": "https://finnhub.io/api/news?id=998ce8e35948f9336367b0ccda5079f1582f31ce7d16131aaf877388a95c08c4"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Advance Late Afternoon",
    "summary": "Health care stocks rose late Monday afternoon with the NYSE Health Care Index and the Health Care Se",
    "url": "https://finnhub.io/api/news?id=a258aff69c7ffab5f5dd0718fb0e44ec24bee1076170a557b05c74c80f4ac635",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758570850,
      "headline": "Sector Update: Health Care Stocks Advance Late Afternoon",
      "id": 136844882,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Health care stocks rose late Monday afternoon with the NYSE Health Care Index and the Health Care Se",
      "url": "https://finnhub.io/api/news?id=a258aff69c7ffab5f5dd0718fb0e44ec24bee1076170a557b05c74c80f4ac635"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock Jumps On Bold $4.7 Billion Metsera Acquisition Bet",
    "summary": "Pfizer Stock Jumps As $4.7B Metsera Buyout Targets Obesity Drug Boom",
    "url": "https://finnhub.io/api/news?id=5e15e9fc43d470830150f8c59d79a21f96e4e5bf57254111afd30efb79c949c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758562274,
      "headline": "Pfizer Stock Jumps On Bold $4.7 Billion Metsera Acquisition Bet",
      "id": 136850989,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer Stock Jumps As $4.7B Metsera Buyout Targets Obesity Drug Boom",
      "url": "https://finnhub.io/api/news?id=5e15e9fc43d470830150f8c59d79a21f96e4e5bf57254111afd30efb79c949c5"
    }
  },
  {
    "ts": null,
    "headline": "Why Pfizer Stock Just Popped",
    "summary": "Pfizer's own GLP-1 drug candidate failed earlier this year -- so it's buying someone else's.",
    "url": "https://finnhub.io/api/news?id=866db96511ebd19f53ab4565adfc29252823f031d75407d85229256a364dd2d1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758562083,
      "headline": "Why Pfizer Stock Just Popped",
      "id": 136850990,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer's own GLP-1 drug candidate failed earlier this year -- so it's buying someone else's.",
      "url": "https://finnhub.io/api/news?id=866db96511ebd19f53ab4565adfc29252823f031d75407d85229256a364dd2d1"
    }
  },
  {
    "ts": null,
    "headline": "US Equity Indexes Add to Last Week's Record Highs as Gold Scales New Peak",
    "summary": "US benchmark stock indexes rose in midday trading on Monday as safe-haven asset gold touched a new a",
    "url": "https://finnhub.io/api/news?id=0d7e4a52a96c20904876f0981be32365b2a093da7aec7ab78c8db1ce51b00d37",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758560502,
      "headline": "US Equity Indexes Add to Last Week's Record Highs as Gold Scales New Peak",
      "id": 136850991,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "US benchmark stock indexes rose in midday trading on Monday as safe-haven asset gold touched a new a",
      "url": "https://finnhub.io/api/news?id=0d7e4a52a96c20904876f0981be32365b2a093da7aec7ab78c8db1ce51b00d37"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market Today: Dow Up As Nvidia Pops; EV Play Skids On Warren Buffett Move (Live Coverage)",
    "summary": "Stock Market Today: Dow Up As Nvidia Pops; EV Play Skids On Warren Buffett Move (Live Coverage)",
    "url": "https://finnhub.io/api/news?id=c51d4d84da1f1c0b763e971c8be10ba47cf230ba7399d2d2e60b8f100cc18adb",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758557897,
      "headline": "Stock Market Today: Dow Up As Nvidia Pops; EV Play Skids On Warren Buffett Move (Live Coverage)",
      "id": 136867108,
      "image": "",
      "related": "PFE",
      "source": "DowJones",
      "summary": "Stock Market Today: Dow Up As Nvidia Pops; EV Play Skids On Warren Buffett Move (Live Coverage)",
      "url": "https://finnhub.io/api/news?id=c51d4d84da1f1c0b763e971c8be10ba47cf230ba7399d2d2e60b8f100cc18adb"
    }
  },
  {
    "ts": null,
    "headline": "Metsera: Long-Acting MET-097i And Product Differentiation Nets Pfizer Acquisition",
    "summary": "Metsera, Inc. is being acquired by Pfizer Inc. for up to $7.3 billion, driven by its innovative obesity drug pipeline. Click to read why MTSR is a Strong Buy.",
    "url": "https://finnhub.io/api/news?id=672546e5b973028908d86da56bd98a1fa63364fadd28e94952e97f8445426233",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758556556,
      "headline": "Metsera: Long-Acting MET-097i And Product Differentiation Nets Pfizer Acquisition",
      "id": 136844155,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2223801264/image_2223801264.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Metsera, Inc. is being acquired by Pfizer Inc. for up to $7.3 billion, driven by its innovative obesity drug pipeline. Click to read why MTSR is a Strong Buy.",
      "url": "https://finnhub.io/api/news?id=672546e5b973028908d86da56bd98a1fa63364fadd28e94952e97f8445426233"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. (PFE) Discusses On Proposed Acquisition Of Metsera, Inc. Call (Transcript)",
    "summary": "Pfizer Inc. (PFE) Discusses On Proposed Acquisition Of Metsera, Inc. Call (Transcript)",
    "url": "https://finnhub.io/api/news?id=05b8d31bef0075213346a85ec2701b15075531ac64e8b00fcddb6a264aac128b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758548893,
      "headline": "Pfizer Inc. (PFE) Discusses On Proposed Acquisition Of Metsera, Inc. Call (Transcript)",
      "id": 136843334,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=05b8d31bef0075213346a85ec2701b15075531ac64e8b00fcddb6a264aac128b"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. (PFE) Proposed Acquisition of Metsera, Inc.",
    "summary": "2025-09-22. The following slide deck was published by Pfizer Inc.",
    "url": "https://finnhub.io/api/news?id=44dc5f6d7de76ee28988f7af982b0a79705027aa628727b33353e5de12438f97",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758548865,
      "headline": "Pfizer Inc. (PFE) Proposed Acquisition of Metsera, Inc.",
      "id": 136843335,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "2025-09-22. The following slide deck was published by Pfizer Inc.",
      "url": "https://finnhub.io/api/news?id=44dc5f6d7de76ee28988f7af982b0a79705027aa628727b33353e5de12438f97"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. (PFE) M&A Call Transcript",
    "summary": "Pfizer Inc. (NYSE:PFE) M&A Call September 22, 2025 8:00 AM EDTCompany ParticipantsFrancesca DeMartino - Chief Investor Relations OfficerChris Boshoff -...",
    "url": "https://finnhub.io/api/news?id=d897421aef7bb5bec3952c9313fefd721fa7f8e01727c7f2663ebeacf8ee46ff",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758548028,
      "headline": "Pfizer Inc. (PFE) M&A Call Transcript",
      "id": 136843260,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer Inc. (NYSE:PFE) M&A Call September 22, 2025 8:00 AM EDTCompany ParticipantsFrancesca DeMartino - Chief Investor Relations OfficerChris Boshoff -...",
      "url": "https://finnhub.io/api/news?id=d897421aef7bb5bec3952c9313fefd721fa7f8e01727c7f2663ebeacf8ee46ff"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer to buy obesity drug developer Metsera for up to USD7.3 billion",
    "summary": "Pfizer to buy obesity drug developer Metsera for up to USD7.3 billion",
    "url": "https://finnhub.io/api/news?id=95761c3d7c880e58c411ee3784d3d44ba40ddf5c89d85b85af23d53a11cd2a27",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758541787,
      "headline": "Pfizer to buy obesity drug developer Metsera for up to USD7.3 billion",
      "id": 136842192,
      "image": "",
      "related": "PFE",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=95761c3d7c880e58c411ee3784d3d44ba40ddf5c89d85b85af23d53a11cd2a27"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: Metsera Acquisition Is The Missing Piece Of The Obesity Puzzle",
    "summary": "Pfizer Inc. acquires Metsera, Inc. for up to $7.5B, boosting its obesity pipeline with new therapies. Click for potential FDA action and the impact on PFE and MTSR.",
    "url": "https://finnhub.io/api/news?id=19babe5762d139880f0fd0145590c8b38d0f9dfcad1c250d24d334e5d7fb97ea",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758540434,
      "headline": "Pfizer: Metsera Acquisition Is The Missing Piece Of The Obesity Puzzle",
      "id": 136842761,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2222078293/image_2222078293.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer Inc. acquires Metsera, Inc. for up to $7.5B, boosting its obesity pipeline with new therapies. Click for potential FDA action and the impact on PFE and MTSR.",
      "url": "https://finnhub.io/api/news?id=19babe5762d139880f0fd0145590c8b38d0f9dfcad1c250d24d334e5d7fb97ea"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Jumps Back Into the Weight-Loss Race With $4.9B Acquisition",
    "summary": "Pfizer Jumps Back Into the Weight-Loss Race With $4.9B Acquisition",
    "url": "https://finnhub.io/api/news?id=a6cb978cb0ac3c882ec485fd64b2f26ef9f3be4f17c0ed881e3516fe967db21a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758539820,
      "headline": "Pfizer Jumps Back Into the Weight-Loss Race With $4.9B Acquisition",
      "id": 136867273,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Jumps Back Into the Weight-Loss Race With $4.9B Acquisition",
      "url": "https://finnhub.io/api/news?id=a6cb978cb0ac3c882ec485fd64b2f26ef9f3be4f17c0ed881e3516fe967db21a"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion",
    "summary": "Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion",
    "url": "https://finnhub.io/api/news?id=c7d14e61e49141709b6db49232fe6dc265c1b800d45ca00ffb6c5bc621761bc7",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758538440,
      "headline": "Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion",
      "id": 136867246,
      "image": "",
      "related": "PFE",
      "source": "DowJones",
      "summary": "Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion",
      "url": "https://finnhub.io/api/news?id=c7d14e61e49141709b6db49232fe6dc265c1b800d45ca00ffb6c5bc621761bc7"
    }
  },
  {
    "ts": null,
    "headline": "PRESS: Pfizer closer to buying Metsera for up to USD7.3 billion - FT",
    "summary": "PRESS: Pfizer closer to buying Metsera for up to USD7.3 billion - FT",
    "url": "https://finnhub.io/api/news?id=b840a5db26d301f520103adff856f447e451f33116914b153504e3ce9076f6e1",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758536598,
      "headline": "PRESS: Pfizer closer to buying Metsera for up to USD7.3 billion - FT",
      "id": 136841791,
      "image": "",
      "related": "PFE",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=b840a5db26d301f520103adff856f447e451f33116914b153504e3ce9076f6e1"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Buys Obesity Drug Developer Metsera: Buy Today And Benefit From CVRs",
    "summary": "Pfizer Inc. acquires Metsera, Inc. to re-enter the obesity drug market. Click for my look at PFZ and MTSR stock and where I see value in the weight loss sector.",
    "url": "https://finnhub.io/api/news?id=5bfff513063fe49ab6c7824a71faf28231baceff3d5fefb0fa928a0b51860a29",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758536408,
      "headline": "Pfizer Buys Obesity Drug Developer Metsera: Buy Today And Benefit From CVRs",
      "id": 136842565,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1299632091/image_1299632091.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer Inc. acquires Metsera, Inc. to re-enter the obesity drug market. Click for my look at PFZ and MTSR stock and where I see value in the weight loss sector.",
      "url": "https://finnhub.io/api/news?id=5bfff513063fe49ab6c7824a71faf28231baceff3d5fefb0fa928a0b51860a29"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer makes a $4.9 billion bet on obesity drugs with Metsera buyout deal",
    "summary": "Pfizer makes a $4.9 billion bet on obesity drugs with Metsera buyout deal",
    "url": "https://finnhub.io/api/news?id=3c155838960e028f2b5f68860dcf2751d941b53cc860e06b945fa94a2fe074ef",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758528840,
      "headline": "Pfizer makes a $4.9 billion bet on obesity drugs with Metsera buyout deal",
      "id": 136869776,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer makes a $4.9 billion bet on obesity drugs with Metsera buyout deal",
      "url": "https://finnhub.io/api/news?id=3c155838960e028f2b5f68860dcf2751d941b53cc860e06b945fa94a2fe074ef"
    }
  },
  {
    "ts": null,
    "headline": "Metsera Shares Leap Premarket on Report of Takeover by Pfizer",
    "summary": "Metsera Shares Leap Premarket on Report of Takeover by Pfizer",
    "url": "https://finnhub.io/api/news?id=6bc56515906005533d21f5ae87f2e8f3f0d5154ee842efee8bf3b34265caa40c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758520680,
      "headline": "Metsera Shares Leap Premarket on Report of Takeover by Pfizer",
      "id": 136869777,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Metsera Shares Leap Premarket on Report of Takeover by Pfizer",
      "url": "https://finnhub.io/api/news?id=6bc56515906005533d21f5ae87f2e8f3f0d5154ee842efee8bf3b34265caa40c"
    }
  }
]